The Positive Study Of Financial Failure In Synthetic Pharmaceutical

This year, my business and the emergence of financial mismanagement of individual failures have become increasingly widespread; the problem not only exists in state-owned enterprises, collective enterprises, private enterprises and individual enterprises, also exist in "transforming" business. They do not establish a modern enterprise system, and thus did not establish a corresponding corporate governance structure mechanism, so naturally there is no effective financial management structure will inevitably lead to financial failure. Southwest Synthetic Pharmaceutical Co, Ltd. (hereinafter also known as "synthetic pharmaceutical") is a typical "transforming" company, and therefore the pharmaceutical companies here in the southwest for synthetic samples to the company through financial failure analysis to identify underlying causes and direct causes.The reasons for the failure of the financial "transforming" companies are both in the existence of common, and their individuality. In this paper, the author from the following reasons for the failure of the south-west of synthetic pharmaceutical financial analysis:In terms of structure, "transforming"companies still have many serious problems, such as excessively high proportion of state shares, the shareholders of the company led the operator supervision and restraint mechanisms empty home, a phenomenon of internal control; with the controlling shareholders of listed companies are not strictly divided by the "three separation". Dual representation of senior managers, led directly to the management of chaos: restructuring incompletely, not strictly separating non-operating assets and bad assets, bring tremendous burden to the operating of companies; Factors from the company shows that business decisions are not part of the company into the mire. Such companies do not have scale operation of blind...